The global cystic fibrosis therapeutics market grew at a CAGR of around 15% during 2014-2019. Cystic fibrosis (CF) is a progressive disease affecting the cells that produce mucus, sweat and digestive tissues. Its symptoms include persistent coughing, frequent lung infections, shortness of breath, bulky stools and male infertility. The CF diagnosis is undertaken by reviewing symptoms, performing a physical examination and conducting several tests. Currently, treatments, including medications, therapies and surgical procedures, are being utilized to ease the symptoms, reduce complications and improve the overall quality of life.

Request for a free sample copy of this report: https://www.imarcgroup.com/cystic-fibrosis-therapeutics-market/requestsample

The rising prevalence of CF, in confluence with the improving healthcare infrastructure, represents one of the key factors impelling the global CF therapeutics market growth. Moreover, leading players are focusing on the introduction of innovative drug combinations that are effective at an early phase of CF. They are also increasing investment in research and development (R&D) projects to develop novel therapies, which is acting as another major growth-inducing factor. Furthermore, rising healthcare expenditures and the widespread adoption of cystic fibrosis transmembrane conductance (CFTR) modulators are expected to create a positive influence on the market growth in the coming years.

Explore full report with table of contents: https://www.imarcgroup.com/cystic-fibrosis-therapeutics-market

Breakup by Drug Class:

• Pancreatic Enzyme Supplements
• Mucolytics
• Bronchodilators
• CFTR Modulators
• Antibiotics
• Others

Breakup by Drug Molecule Type:

• Small Molecule Drugs
• Biologics

Breakup by Route of Administration:

• Oral Drugs
• Inhaled Drugs

Breakup by End-User:

• Hospitals
• Clinics
• Others

Breakup by Region:

• North America
  • United States
  • Canada
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being AbbVie Inc., Alaxia, Alcresta Therapeutics Inc., Allergan, AstraZeneca, F. Hoffmann-La Roche Ltd., Gilead Sciences Inc., Merck & Co. Inc., Novartis AG, Teva Pharmaceutical Industries Ltd., Vertex Pharmaceuticals Inc., etc.

Browse Related Report

https://www.imarcgroup.com/healthcare-it-market

https://www.imarcgroup.com/h1n1-vaccines-market

https://www.imarcgroup.com/weight-management-market

Note: As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the purchase behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

If you want to need latest primary and secondary data (2020-2025) with Cost Module, Business Strategy, Distribution Channel, etc. click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.

Media Contact
Company Name: IMARC Group
Contact Person: Elena Anderson
Email: Send Email
Phone: +1 6317911145
Address:30 N Gould St, Ste R
City: Sheridan
State: WY 82801
Country: United States
Website: https://www.imarcgroup.com/